This HTML5 document contains 210 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1182/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36755484
rdf:type
wikibase:Item
schema:description
artikel ilmiah наукова стаття, опублікована в січні 2016 2016年论文 article scientifique wetenschappelijk artikel artículu científicu espublizáu en 2016 2016年論文 artículo científico publicado en 2016 2016 nî lūn-bûn мақолаи илмӣ 2016년 논문 videnskabelig artikel 2016年論文 artigo científico научна статия tieteellinen artikkeli 2016年の論文 tudományos cikk 2016年论文 artikull shkencor article científic 2016年論文 wissenschaftlicher Artikel ২৯ জানুয়ারি ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научни чланак artigo científico scientific article published on 29 January 2016 scientific article published on 29 January 2016 2016年论文 articolo scientifico article scientific vědecký článek bài báo khoa học บทความทางวิทยาศาสตร์ vetenskaplig artikel vitenskapelig artikkel 2016年论文 2016年論文 სამეცნიერო სტატია مقالة علمية نشرت في 29 يناير 2016 scienca artikolo artykuł naukowy vitskapeleg artikkel vedecký článok 2016年论文 articol științific επιστημονικό άρθρο 2016年論文 teaduslik artikkel artigo científico naučni članak научная статья bilimsel makale מאמר מדעי scientific article published on 29 January 2016 научни чланак 2016年论文 artikulong pang-agham
p:P577
wds:Q36755484-16E58C52-CA68-440D-8DA9-284A1F671A5E
wdt:P577
2016-01-29T00:00:00Z
p:P407
wds:Q36755484-D64DB364-53D6-482E-A36E-4EA1B82B3A18
wdt:P407
wd:Q1860
p:P2860
wds:Q36755484-08835DB2-8E0A-4756-BEE1-3FC04EB7EA6D wds:Q36755484-145ADFD7-61BE-4F3D-B518-2B175A6C9659 wds:Q36755484-17596C26-2299-4145-A2C3-1E89A55D8741 wds:Q36755484-2660FE63-5185-4598-9D28-66683BA22F56 wds:Q36755484-CE4A7A41-8A0F-47D0-B827-436859A5B938 wds:Q36755484-EBFF84E0-0F78-4EFB-8B23-A0659A5A4BAB wds:Q36755484-20100DB0-92DE-45AC-A1A0-4BAE7C33E387 wds:Q36755484-438DE023-A9ED-4333-9251-64A2866EC510 wds:Q36755484-4555669B-8AAC-4130-ADB2-E32B36BAC7A8 wds:Q36755484-344DC4DE-CF75-45A9-896E-260FCCB31EAC wds:Q36755484-34D6B150-AF9E-4312-861F-CDCBE8396956 wds:Q36755484-FC4125B9-C135-4307-A995-24C644BA25D3 wds:Q36755484-6FAA0B1F-8D2E-4720-B33C-98C316AB1F11 wds:Q36755484-659D5BEA-93A3-433D-9AC9-B8C741A8532B wds:Q36755484-A4160D5F-59B5-4DC0-8B46-30E10D3182B5 wds:Q36755484-AAFFD82E-50D4-4250-8D53-AE81EECF2DD6 wds:Q36755484-7BA15749-DD35-4E38-A652-DD70E80135C8 wds:Q36755484-8552C3A1-7DD7-48CB-99B9-CF67EE8F022E wds:Q36755484-8672571A-E865-4328-BDFE-227BDA0661EA wds:Q36755484-8867A283-650B-485B-99A8-FF47A11124DA wds:Q36755484-BFDEC33C-A5A9-4099-829D-90530ACF55D8 wds:Q36755484-C1A290A0-2E29-4C23-95AB-7D6F8C704889 wds:Q36755484-C24BBCCB-9BBE-48DA-A15A-EA14F0984FA7 wds:Q36755484-C6B44774-BAF6-47F5-834D-5A8F66CF8AF4 wds:Q36755484-B6B3293B-54A6-42E9-9E62-A5C1626B2BBE
wdt:P2860
wd:Q44189562 wd:Q34195684 wd:Q35126479 wd:Q47781836 wd:Q42737854 wd:Q50112405 wd:Q79351921 wd:Q38288208 wd:Q43266069 wd:Q39688572 wd:Q80213795 wd:Q46744470 wd:Q34207695 wd:Q48248040 wd:Q39605645 wd:Q44431711 wd:Q46917405 wd:Q73416359 wd:Q34479575 wd:Q82711209 wd:Q73720194 wd:Q73756692 wd:Q37001941 wd:Q37988027 wd:Q34121577
p:P2093
wds:Q36755484-A62DB141-EBC0-4AC4-B5C2-37302A0E7DCA wds:Q36755484-A4CC4939-760B-4B81-87A3-34E8255C966E wds:Q36755484-B661C29D-A819-4328-A559-8039C74ADD97 wds:Q36755484-4DB72E36-43FC-4382-BEBE-A0D453FA14C5 wds:Q36755484-53BAB9D1-8C1E-4368-8BF4-99FD5223548F wds:Q36755484-52770FF9-2BEE-4B75-8A7A-DF3257E8CE8D wds:Q36755484-261D1F31-64C0-4B2D-8731-08067F6BB051 wds:Q36755484-3078B146-1247-45D6-A910-D3FF14E528B2 wds:Q36755484-2B2452BC-9D72-44F5-961F-AA69A94AD651 wds:Q36755484-73A3E38F-DFC6-4B6E-8E80-3F70E15EFBDB wds:Q36755484-3B38DB70-860D-452C-8580-A9B0F0AC2640 wds:Q36755484-41424E92-5AB9-4B60-A840-F35824B20A2B wds:Q36755484-CC08C4A9-BD76-453C-9DBE-96985B4B3DE5 wds:Q36755484-C862BAB5-0451-42DA-860A-4B8E435B9592 wds:Q36755484-CA41D58E-B42E-4E06-950F-4F0CC210135D wds:Q36755484-DA462D31-7551-4A80-8D71-18EA8DA7A7AB wds:Q36755484-D0022E46-3382-4950-AF6E-B6626679AFA0 wds:Q36755484-DF0F63B4-951F-44EE-B640-E5AB1961E9C2 wds:Q36755484-E497204C-F122-40BD-8DA2-E6F7855E93D2
wdt:P2093
Diane Warren Eva C Guinan John Doyle Shin Mineishi Bijan Nejadnik Paul L Martin Tulio Rodriguez Maja Miloslavsky Joel A Brochstein Amanda M Termuhlen Marcie L Riches Gideon Steinbach Angela Smith Reggie Duerst Leslie Lehmann Alfred Gillio Rajinder Bajwa Robin L Hume Alison L Hannah
rdfs:label
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure
skos:prefLabel
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure
schema:name
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure
p:P50
wds:Q36755484-FF6C0526-4B58-472E-A50E-4DD2FE6A6E74 wds:Q36755484-DB2F4AAD-636A-47F2-9AA3-1B0FB83918E2 wds:Q36755484-F5044326-61E7-4FF2-9D4F-940089D2475B wds:Q36755484-FAA56A60-2430-41B5-AD9A-2C186DBAA841 wds:Q36755484-B3EF7778-96ED-4D4F-A80B-94FF163E0C8F wds:Q36755484-54C4A0A2-BAF3-45B5-B41C-7332063EE170 wds:Q36755484-607C4727-739A-4EE7-B439-74B037E6E6FF wds:Q36755484-6A563CC7-893E-4F63-B3F5-BB1D7DB1EDD3 wds:Q36755484-6A6999ED-9EB7-46E7-BBCD-ECD804564208 wds:Q36755484-4A837656-5C96-486D-91C1-824B3408701C wds:Q36755484-4CA969EB-1395-4F4E-9271-17AEC917F270 wds:Q36755484-4CE7CD80-5990-43A0-A602-EF7751EDE054 wds:Q36755484-209D3F1D-28FF-4E2D-A83A-57CE25FBA622
wdt:P50
wd:Q46616560 wd:Q89187648 wd:Q87712102 wd:Q66764444 wd:Q104495066 wd:Q117224735 wd:Q117224716 wd:Q114398020 wd:Q59209521 wd:Q92707677 wd:Q89778009 wd:Q59721615 wd:Q37384782
p:P1476
wds:Q36755484-DD25F110-A138-44DF-AEB0-EDD3A96C2637
wdt:P1476
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure
p:P304
wds:Q36755484-DF4C9C6B-998A-427E-911B-FE479F43C78A
wdt:P304
1656-1665
p:P31
wds:Q36755484-547DC650-D6E9-4825-87D7-53AD3BF15ED5
wdt:P31
wd:Q13442814
p:P921
wds:Q36755484-35CAE7E0-3744-4C39-BC23-4A87FA01BD48
wdt:P921
wd:Q42824827
p:P698
wds:Q36755484-2CA2FD3F-F92B-4725-8B24-D26B0C279094
wdtn:P698
n11:26825712
wdt:P698
26825712
p:P1433
wds:Q36755484-B1CC7916-030B-45C9-9820-881608E74A78
wdt:P1433
wd:Q885070
p:P433
wds:Q36755484-596BEC3A-F913-49E5-A028-BA539ED7743C
p:P478
wds:Q36755484-47D05C6D-E51E-44C3-8992-C42848C3F5EE
wdt:P433
13
wdt:P478
127
p:P356
wds:Q36755484-22115259-E6FA-48DF-AC64-2DBF2517BE0B
wdtn:P356
n9:BLOOD-2015-10-676924
wdt:P356
10.1182/BLOOD-2015-10-676924
p:P5875
wds:Q36755484-52D28BDD-6DAF-46B0-A02E-4D1C0A9C7BE8
wdt:P5875
292336562
p:P932
wds:Q36755484-DA0CFD18-C0ED-4348-8DBA-F33AB90C5B8D
wdt:P932
4817309